Ledger.Open graph →
SEC Form D · filed March 29, 2024

Outlook Therapeutics, Inc

Offering
$159.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ISELIN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Nikolaos Perros · New York, NYDirectorC. R. Trenary · Iselin, NJExec · DirectorAvraham D. Dreyfuss · New York, NYDirectorMelvyn Reznick · Reno, NVExec · DirectorKurt J. Hilzinger · Iselin, NJDirectorRajesh Sharma · Saint-Laurent, Quebec, CanadaDirectorRandy H. Thurman · Iselin, NJDirectorMichael A. Barr · Greenwich, CTDirectorDon Maniccia · AUSTIN, TXDirectorFaisal G. Sukhtian · Iselin, NJDirectorM. W. Macey, Jr · Greenwich, CTDirectorLu Cai · New York, NYExec · DirectorAlan Pierrot · Fresno, CADirectorYun Zhang · New York, NYExec · DirectorLawrence A. Kenyon · Iselin, NJExec · DirectorLuke Terrell · Fayetteville, ARDirectorMartin Steyn · Grand Cayman, Cayman IslandsExecJared Hoffman · New York, NYDirectorJeff R. Evanson · Iselin, NJExecXiao Jian Wang · New York, NYDirectorMark H. Barineau · Houston, TXDirectorJames Bracken · Schaumburg, ILDirectorAndong G. Huang · Iselin, NJDirectorJulian G. Gangolli · Iselin, NJDirectorAubrey Rankin · AUSTIN, TXDirectorJoseph J. Gault · Greenwich, CTDirectorJulia A. Haller · Iselin, NJDirectorGerd G. Auffarth · Iselin, NJDirectorYezan H. Haddadin · Iselin, NJDirectorJeff R. Evanson · Iselin, NJExecMichael A. Scott · San Francisco, CADirectorGilles Lamarre · Ottawa, Ontario, CanadaExec · DirectorLei Zhang · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗